Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-296,700
Closed -$647K 2730
2022
Q3
$647K Hold
296,700
﹤0.01% 2491
2022
Q2
$1.04M Hold
296,700
﹤0.01% 2340
2022
Q1
$1.5M Buy
296,700
+26,600
+10% +$135K ﹤0.01% 2200
2021
Q4
$1.69M Hold
270,100
﹤0.01% 2166
2021
Q3
$2.15M Buy
270,100
+10,500
+4% +$86.4K ﹤0.01% 2007
2021
Q2
$1.94M Buy
259,600
+9,500
+4% +$66.3K ﹤0.01% 2120
2021
Q1
$1.51M Buy
250,100
+2,600
+1% +$20K ﹤0.01% 2163
2020
Q4
$1.41M Buy
+247,500
New +$1.57M ﹤0.01% 2122

Other funds holding VXRT

Swiss National Bank's VXRT Position: Q4 2022 in Review

Swiss National Bank sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 296,700 shares — an estimated $647K sold.

Swiss National Bank first reported a position in VXRT in Q4 2020 and held it in 8 quarters. The position peaked at $2.15M in Q3 2021. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Swiss National Bank reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • Swiss National Bank sold 296,700 Vaxart shares in Q4 2022, an estimated $647K.
  • Swiss National Bank first reported a position in Vaxart in Q4 2020 and held it in 8 quarters.
  • Swiss National Bank's Vaxart position peaked at $2.15M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.